Amgen Misses Estimates, Shares Drop
Biotechnology firm Amgen Inc. reported fourth-quarter profits, which fell shy of analysts’ expectations on Thursday, sending its shares lower by 1.6 percent.
By Frank Yu
1/27/2012
Updated: 1/27/2012
Author’s Selected Articles
China Wrestles With Runaway Commodity Prices
May 22, 2021
The Marketing Corner: Social Media Practices
Jan 29, 2017
Tackling the NFL on Taxes
Dec 30, 2013
Friends Read Free